
The CANTAVAC2 Project: Development of translational research for vaccines serums and other biological active compounds.
https://cantacuzino.mapn.ro/pages/cantavac-2-0
Overall CANTAVAC2 Objectives:
- Development of novel profilactic and therapecutic compounds such as tetravalent flue vaccines and therapeutic serums.
- Technology transfer for biological product candidates .
- Integration of AI solutions in the producton workflow of novative products.
- Establishment of a preclinical animal testing facility and its attainment of Good Laboratory Practice (GLP) certification.
- Development of core facilities including a biobank for biologycal material preservation.
Institute of Biochemistry of the Romanian Academy
Team coordinator Dr. Norica Nichita
Contribution to CANTAVAC2
Based on a well documented multidisciplinary expertise in molecular virology, ML-AI technologies, biocomputing and bioinformatics - the IBAR research team consisting in 16 researchers from the Department of Molecular Virology and the Department of Bioinformatics contributes to achieving the CANTAVAC2 project objectives 13 by advancing cutting edge intertwined molecular virology and biocomputing and bioinformatics workflows aimed at (a) the development of novel profilactic and therapecutic compounds; (b) the integration AI-solutions in innovation and production workflows and (c) the transfer of know how and technology to our project partners.
Project co-financed by the European Regional Development Fund through the Health Programul 2021-2027.
Proiect PS/272/PS_P5/OP1/RSO1.1/PS_P5_RSO1.1_A9-CANTAVAC2.0 (MySMIS 326920)
Coordinator: The National Institute of Medical-Military Research-Development "CANTACUZINO",
Coordinator- Dr. Crina Stăvaru
Partners: The Technica Military Academy „Ferdinand I", The National Research Development Institute in Pathology and Biomedical Sciences "Victor Babeş", The Institutul of Biochemistry of the Romanian Academy; Cromatec plus SRL; The Universty of Mecicine and Pharmacy „Grigore T. Popa” Iași; Dorna Medical SRL; The Universty of Mecicine and Pharmacy „Iuliu Hațieganu" Cluj-Napoca și Qualipat SRL; and Pro-vitam SRL;
Romanian Academy